ArticleBMC ophthalmology2025
Transient orbital apex syndrome with magnetic resonance imaging evidence following sub-Tenon's ropivacaine anesthesia during combined cataract and macular surgery: a case report.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundAlthough sub-Tenon’s anesthesia (STA) is a widely accepted regional anesthesia technique in ophthalmic surgery, we report a rare case of transient orbital apex syndrome (OAS) following its administration using ropivacaine during combined cataract and macular surgery. CASE PRESENTATION: We describe the clinical course of a 71-year-old male who developed acute postoperative vision loss, ptosis, ophthalmoplegia, and mydriasis in the operated eye following sub-Tenon’s ropivacaine injection. Orbital MRI revealed mild perineural fluid surrounding the optic nerve and localized edema of the retrobulbar fat, without evidence of compressive lesions or optic nerve thickening. The patient received supportive therapy, including oxygen, neurotrophic agents, and osmotic and microcirculation enhancers. Remarkably, all neurological signs resolved within 24 h, and visual acuity improved to 0.15.
conclusionAlthough STA is considered a safer alternative to needle-based techniques, this case highlights the potential for rare but reversible complications such as OAS. Early recognition and timely, supportive management contributed to the patient’s favorable recovery, although outcomes may vary in other cases. In addition, thorough preoperative counseling and vigilant postoperative monitoring are essential, particularly in elderly or high-risk patients, to ensure prompt detection and management of any unexpected complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.